- Friday, 20 January 2017Regeneus (ASX:RGS) has a busy 2017 to come, spearheaded by its recent entry into the Japanese market for its Progenza product.
- Thursday, 29 December 2016Regeneus has entered into a strategic collaboration and licensing agreement for the manufacture, clinical development and commercialisation of Progenza in the Japanese market.
- Wednesday, 28 December 2016Regeneus (ASX:RGS) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open.
- Thursday, 22 September 2016The Life Sciences Report, published by Streetwise Reports, focuses on biotechnology, pharmaceuticals, medical devices, tools and diagnostics.
- Thursday, 15 September 2016Regeneus Ltd (ASX: RGS) has received $2.73 million from the Australian government as part of a research and development tax refund.